0001213900-19-017904.txt : 20190912
0001213900-19-017904.hdr.sgml : 20190912
20190912211536
ACCESSION NUMBER: 0001213900-19-017904
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190911
FILED AS OF DATE: 20190912
DATE AS OF CHANGE: 20190912
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lowdell Mark William
CENTRAL INDEX KEY: 0001767037
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38793
FILM NUMBER: 191091436
MAIL ADDRESS:
STREET 1: THE OAK, WLX ROAD
CITY: BEAUMONT
STATE: X0
ZIP: CO16 0AT
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inmune Bio, Inc.
CENTRAL INDEX KEY: 0001711754
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 475205835
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1200 PROSPECT STREET
STREET 2: SUITE 525
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 8589643720
MAIL ADDRESS:
STREET 1: 1200 PROSPECT STREET
STREET 2: SUITE 525
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
ownership.xml
X0306
4
2019-09-11
0
0001711754
Inmune Bio, Inc.
INMB
0001767037
Lowdell Mark William
C/O INMUNE BIO INC.,
1200 PROSPECT STREET, SUITE 525
LA JOLLA
CA
92037
0
1
1
0
Chief Scientific Officer
Common Stock
2019-09-11
4
P
0
2918
6.2298
A
1506251
D
The Reporting Person purchased an aggregate of 2,918 shares of the Registrant's common stock on September 11, 2019 in an open market transaction.
/s/ Mark Lowdell
2019-09-12